SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
6 references·0 citing·23 second hop
Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer (1999)Cost-effectiveness of paclitaxel plus cis…Cost of combined modality interventions for stage III non-small-cell lung cancer. (1997)Cost of combined modality int…Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. (1995)Estimating the cost of lung c…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Canadian Coordinating Office for Health Technology Assessment. (1992)Canadian Coordinating Office …Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. (1990)Counting the costs of chemoth…A Clinician's Guide to Cost-Effectiveness Analysis (1990)A Clinician's Guide to Cost-E…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide (1994)Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer (1995)Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. (1998)Cost Accounting: A Managerial Emphasis, (2010)Alternative to Mental Hospital Treatment (1980)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)A study of the quality of life and cost-utility of renal transplantation (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)The Distinction Between Cost and Charges (1982)Markov Models in Medical Decision Making (1993)The rand 36‐item health survey 1.0 (1993)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. (1988)POHEM--a framework for understanding and modelling the health of human populations. (1994)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Criteria for evaluating evidence on public health interventions (2002)Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System (2002)Canada's Population Health Model (POHEM) (2001)Epidemiology and demography in public health (2010)Economic Burden for Lung Cancer Survivors in Urban China (2017)
this work references cited by second hop

References

  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1990A Clinician's Guide to Cost-Effectiveness Analysis707 cited
  • 1992Canadian Coordinating Office for Health Technology Assessment.293 cited
  • 1990Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.205 cited
  • 1995Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.60 cited
  • 1997Cost of combined modality interventions for stage III non-small-cell lung cancer.52 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work